结直肠癌根治术后并发症的影响因素分析

Analysis of influencing factors for complications after radical resection of colorectal cancer

  • 摘要:
    探讨结直肠癌根治术后并发症的影响因素。
    采用回顾性病例对照研究方法。收集2016年1月至2020年12月汕头大学医学院第一附属医院收治的347例原发性结直肠癌患者的临床资料;男200例,女147例;年龄为(63±11)岁。观察指标:(1)术后并发症情况。(2)结直肠癌根治术后发生并发症的影响因素分析。(3)术前不同血清胆碱酯酶水平患者临床特征比较。正态分布的计量资料组间比较采用独立样本t检验,偏态分布的计量资料组间比较采用Mann⁃Whitney U检验;计数资料组间比较采用χ2检验。绘制受试者工作特征曲线计算最佳截断值。单因素和多因素分析采用Logistic回归模型。
    (1)术后并发症情况。347例患者中,117例发生术后并发症,其中Clavien⁃Dindo分级Ⅰ、Ⅱ级75例,Ⅲ、Ⅳ级42例。(2)结直肠癌根治术后发生并发症的影响因素分析。应用受试者工作特征曲线确定术前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值、白蛋白、血清胆碱酯酶、癌胚抗原识别结直肠癌根治术后发生并发症的最佳截断值分别为2.13、132.72、3.71、36.92 g/L、7 436.50 U/L、7.90 ng/mL。多因素分析结果显示:术前血清胆碱酯酶<7 436.50 U/L、美国麻醉医师协会(ASA)分级>2级均是影响结直肠癌根治术后发生并发症的独立危险因素(风险比=2.928,2.214,95%可信区间为1.699~5.047,1.109~4.420,P<0.05)。(3)术前不同血清胆碱酯酶水平患者临床特征比较。120例术前高血清胆碱酯酶(≥7 436.50 U/L)患者和227例术前低血清胆碱酯酶(<7 436.50 U/L)患者年龄分别为60.38(54.00,67.00)岁和62.93(56.00,70.00)岁、体质量指数分别为(23.11±3.02)kg/m2和(21.68±3.49)kg/m2、骨骼肌面积指数分别为41.68(37.89,45.34)cm2/m2和39.56(34.60,44.29)cm2/m2、中性粒细胞与淋巴细胞比值分别为1.84(1.45,2.37)和2.23(1.59,3.16)、血小板与淋巴细胞比值分别为124.01(93.74,160.29)和143.82(106.52,204.72)、淋巴细胞与单核细胞比值分别为4.26(3.29,5.41)和3.47(2.57,4.52)、白蛋白分别为38.80(36.75,41.30)g/L和35.50(32.20,38.50)g/L、血红蛋白分别为130.33(120.00,140.75)g/L和115.36(103.00,132.00)g/L、肿瘤位置结肠分别为49、149例和肿瘤位置直肠分别为71、78例、T分期T1~2期分别为29、31例和T分期T3期分别为91、196例、术后并发症分别为22例和95例,两者上述指标比较,差异均有统计学意义(Z=-2.669,t=3.787,Z=-2.542、-3.564、-3.863、-3.871、-7.595、-5.872,χ2=19.714、6.064,19.426,P<0.05)。
    术前血清胆碱酯酶<7 436.50 U/L、ASA分级>2级均是结直肠癌患者根治术后发生并发症的独立危险因素。与术前高血清胆碱酯酶患者比较,术前低血清胆碱酯酶患者年龄更大、T3期占比更高、全身炎症状态更显著、营养状况更差、术后发生并发症的占比更高。

     

    Abstract:
    Objective To investigate the influencing factors for complications after radical resection of colorectal cancer.
    Methods The retrospective case-control study was conducted. The clinical data of 347 patients with primary colorectal cancer who were admitted to The First Affiliated Hospital of Shantou University Medical College from January 2016 to December 2020 were collected. There were 200 males and 147 females, aged (63±11)years. Observation indicators: (1) incidence of postoperative complications; (2) analysis of factors associated with postoperative complications after radical resection of colorectal cancer; (3) comparison of clinical characteristics of patients with different preoperative serum cholinesterase. Comparison of measurement data with normal distri-bution between groups was conducted using the independent sample t test. Comparison of measure-ment data with skewed distribution between groups was conducted using the Mann-Whitney U test. Comparison of count data between groups was conducted using the chi-square test. The rceiver operating characteristic (ROC) curves were plotted to determine the optimal cut-off values. Univariate and multivariate analyses were conducted using the Logistic regression model.
    Results (1) Incidence of postoperative complications. Of 347 patients, 117 cases developed postoperative complications, including 75 cases with Clavien-Dindo grade Ⅰ-Ⅱ complications and 42 cases with Clavien-Dindo grade Ⅲ-Ⅳ complications. (2) Analysis of factors associated with postoperative complications after radical resection of colorectal cancer. ROC curve analysis determined the optimal cut-off values for preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, albumin, serum cholinesterase, and carcinoembryonic antigen to identify postoperative com-plications after radical resection of colorectal cancer as 2.13, 132.72, 3.71, 36.92 g/L, 7 436.50 U/L, and 7.90 ng/mL, respectively. Multivariate analysis identified preoperative serum cholinesterase <7 436.50 U/L, and American Society of Anesthesiologists (ASA) classification >grade 2 as indepen-dent risk factors influencing postoperative complications after radical resection of colorectal cancer (hazard ratio=2.928, 2.214, 95% confidence interval as 1.699-5.047, 1.109-4.420, P<0.05). (3) Comparison of clinical characteristics of patients with different preoperative serum cholinesterase. There were 120 patients with preoperative high serum cholinesterase (≥7 436.50 U/L) and 227 pati-ents with preoperative low serum cholinesterase (<7 436.50 U/L). Age of patients with preoperative high and low serum cholinesterase was 60.38(54.00,67.00)years and 62.93(56.00,70.00)years, the body mass index was (23.11±3.02)kg/m2 and (21.68±3.49)kg/m2, and the skeletal muscle area index was 41.68(37.89,45.34)cm2/m2 and 39.56(34.60,44.29)cm2/m2, the neutrophil-to-lymphocyte ratio was 1.84(1.45,2.37) and 2.23(1.59,3.16), the platelet-to-lymphocyte ratio was 124.01(93.74,160.29) and 143.82(106.52,204.72), the lymphocyte-to-monocyte ratio was 4.26(3.29,5.41) and 3.47(2.57,4.52), the albumin was 38.80(36.75,41.30)g/L and 35.50(32.20,38.50)g/L, the hemoglobin was 130.33(120.00,140.75)g/L and 115.36(103.00,132.00)g/L, cases with tumor location at colon were 49 and 149, cases with tumor location at rectus were 71 and 78, cases with tumor of T1-2 stage were 29 and 31, cases with tumor of T3 stage were 91 and 196, cases with postoperative overall complications were 22 and 95, respectively, showing significant differences in the above indicators between them (Z=-2.669, t=3.787, Z=-2.542, -3.564, -3.863, -3.871, -7.595, -5.872, χ2=19.714, 6.064, 19.426, P<0.05).
    Conclusion Preoperative serum cholinesterase <7 436.50 U/L and ASA classification >grade 2 are independent risk factors influen-cing postoperative complications after radical resection of colorectal cancer. Compared to patients with preoperative high serum cholines-terase, patients with preoperative low serum cholinesterase are older, with higher proportion of T3 stage tumors, more pronounced systemic inflammatory state, poorer nutritional status, and high incidence of postoperative complications.

     

/

返回文章
返回